These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hepatitis C virus therapy to date. Foster G; Mathurin P Antivir Ther; 2008; 13 Suppl 1():3-8. PubMed ID: 18432157 [TBL] [Abstract][Full Text] [Related]
7. Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference? Sierra F J Hepatol; 2007 Feb; 46(2):349; author reply 349-50. PubMed ID: 17161495 [No Abstract] [Full Text] [Related]
8. Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction. Keeffe EB Semin Liver Dis; 2003; 23 Suppl 1():1-2. PubMed ID: 12934161 [No Abstract] [Full Text] [Related]
9. Successful pegylated interferon alpha2a monotherapy for hepatitis C virus infection in a transplanted patient who relapsed after the preceding course. Ichikawa T; Taura N; Miyaaki H; Matsuzaki M; Eguchi S; Takatsuki M; Kanematsu T; Nakao K Transpl Infect Dis; 2011 Aug; 13(4):438-40. PubMed ID: 21309967 [No Abstract] [Full Text] [Related]
10. [Assessment and monitoring of patients with chronic hepatitis C on antiviral therapy--state of the art in 2003]. Simon K; Szymczak A Pol Arch Med Wewn; 2004 Jul; 112(1):891-8. PubMed ID: 15526854 [No Abstract] [Full Text] [Related]
16. Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Kamal SM; Ismail A; Graham CS; He Q; Rasenack JW; Peters T; Tawil AA; Fehr JJ; Khalifa Kel S; Madwar MM; Koziel MJ Hepatology; 2004 Jun; 39(6):1721-31. PubMed ID: 15185314 [TBL] [Abstract][Full Text] [Related]
17. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Malnick SD; Basevitch A Gastroenterology; 2006 Aug; 131(2):683; author reply 683-4. PubMed ID: 16890628 [No Abstract] [Full Text] [Related]
18. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo. Inoue K; Umehara T; Ruegg UT; Yasui F; Watanabe T; Yasuda H; Dumont JM; Scalfaro P; Yoshiba M; Kohara M Hepatology; 2007 Apr; 45(4):921-8. PubMed ID: 17393519 [TBL] [Abstract][Full Text] [Related]
19. Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence. Watashi K; Metselaar HJ; van der Laan LJ Liver Transpl; 2008 Mar; 14(3):265-7. PubMed ID: 18306373 [No Abstract] [Full Text] [Related]
20. Peginterferon alfa-2a (Pegasys) for chronic hepatitis C. Med Lett Drugs Ther; 2003 Mar; 45(1151):19-20. PubMed ID: 12612502 [No Abstract] [Full Text] [Related] [Next] [New Search]